DNA Edit: Shortchanging victims - Cancer gets the upper hand due to institutional apathy

Cancer

Picture for representation

There is an epidemic of cancer today in India and over 83 per cent of cancer patients in India are receiving wrong treatment. Last year about 12 lakh cases were reported, a jump of two lakh cases from six years ago. Despite the rising incidence, quality treatment is in short supply. Patients are being prescribed wrong drugs, and many of them aren’t encouraged to complete the set of tests required for treatment. The Indian Council of Medical Research (ICMR) puts the figure of cancer-related deaths at 8,80,000 while the number of new cancer cases is estimated to be over 1.73 million by 2020. The treatment of cancer is expensive, driving many families to penury. Cancer puts a huge economic burden on India. Treatment for only 40 per cent of cancer hospitalization cases is financed mainly through borrowings, the sale of assets and contributions from friends and relatives. Also, over 60 per cent of the households who seek care from the private sector incur out of pocket expenditure in excess of 20 per cent of their annual per capita household expenditure. On top of that, if the quality of treatment is so poor, it shows a complete lack of accountability of the public and private healthcare systems. Cancer requires a multidisciplinary approach involving a team of specialists. According to the National Cancer Grid, there are only 62 dedicated cancer care hospitals in the country, including both regional and national facilities. It’s too small a number to cater to the growing number of patients.